Compare AWI & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AWI | BLCO |
|---|---|---|
| Founded | 1860 | 1853 |
| Country | United States | Canada |
| Employees | N/A | 13000 |
| Industry | Plastic Products | Ophthalmic Goods |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 6.1B |
| IPO Year | 1994 | 2022 |
| Metric | AWI | BLCO |
|---|---|---|
| Price | $162.94 | $16.94 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 14 |
| Target Price | ★ $210.18 | $19.04 |
| AVG Volume (30 Days) | 271.0K | ★ 313.5K |
| Earning Date | 10-27-2026 | 10-28-2026 |
| Dividend Yield | ★ 0.83% | N/A |
| EPS Growth | ★ 17.61 | N/A |
| EPS | ★ 3.81 | N/A |
| Revenue | $1,620,800,000.00 | ★ $5,101,000,000.00 |
| Revenue This Year | $10.24 | $7.71 |
| Revenue Next Year | $7.20 | $5.86 |
| P/E Ratio | $42.70 | ★ N/A |
| Revenue Growth | ★ 12.11 | 6.47 |
| 52 Week Low | $150.28 | $13.77 |
| 52 Week High | $206.08 | $18.92 |
| Indicator | AWI | BLCO |
|---|---|---|
| Relative Strength Index (RSI) | 40.49 | 49.12 |
| Support Level | $159.60 | $16.94 |
| Resistance Level | $162.38 | $17.21 |
| Average True Range (ATR) | 3.50 | 0.39 |
| MACD | 0.28 | -0.03 |
| Stochastic Oscillator | 44.90 | 45.28 |
Armstrong World Industries Inc designs and manufactures exterior architectural applications, including ceilings, specialty walls, and exterior metal solutions, using materials such as mineral fiber, fiberglass, metal, felt, architectural resin and glass, wood, wood fiber, and glass-reinforced-gypsum. Its segments include Mineral Fiber, which produces suspended mineral fiber and fiberglass ceiling systems and includes results from the Worthington Armstrong Venture (WAVE) for ceiling suspension system (grid) products; Architectural Specialties, which designs, produces, and sources specialty ceilings, walls, and other architectural applications for commercial settings, with revenues mainly project driven; and Unallocated Corporate. The company operates in the United States and Canada.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.